From the publishers of JADPRO

CAR T-Cell Therapy Resource Center

Advertisement

Interview With Kendra Yum, PharmD, BCOP, on CAR T-Cell Therapy: A Primer on Mechanisms of Action

Welcome to the CAR T-Cell Therapy Resource Center! Take a look around and find current information, news, literature, and other resources from this area of oncology treatment. We hope this site is helpful to your practice. If you have any feedback or questions, please contact editor@advancedpractitioner.com

Kathryn Ciccolini AGACNP-BC, DNP, MSN, OCN

Kathryn Ciccolini, AGACNP-BC, DNP, MSN, OCN
CAR-T/BMT Clinical Program Manager
Bone Marrow and Stem Cell Transplantation Program
Mount Sinai Hospital

American Cancer Society: CAR T-Cell Therapy and its Side Effects

ASTCT NucleusPlus: Insights on Emerging CAR-T Therapies

SITC Clinical Practice Guideline on Immune Effector Cell-related Adverse Events

ASH-ASTCT COVID-19 Vaccination for HCT and CAR T Cell Recipients: Frequently Asked Questions

Leukemia and Lymphoma Society: CAR T-Cell Therapy

Journal for ImmunoTherapy of Cancer

Thrombopoietin Receptor Agonists for Acquired Thrombocytopenia Following Anti-CD19 CAR-T-Cell Therapy: A Case Report

Clinical Infectious Diseases

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Frontiers in Oncology

New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

The Lancet

KTE-X19 for Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukaemia: Phase 2 Results of the Single-Arm, Open-Label, Multicentre ZUMA-3 Study

Clinical Cancer Research

Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients With Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel

Journal of Cancer

Current Progress in CAR-T Cell Therapy for Hematological Malignancies

Nature Reviews Clinical Oncology

Engineering Strategies to Overcome the Current Roadblocks in CAR T Cell Therapy

Journal of the Advanced Practitioner in Oncology

CAR T-Cell Therapy: Adverse Events and Management

Journal of Clinical Oncology

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

The ASCO Post

Early-Phase Study Explores CAR T-Cell Therapy for Relapsed or Refractory B-Cell Lymphoma

Fast Facts #2: Immunology Basics